KMR Group Assesses Discovery Research In Biopharma Industry

KMR GROUP, a firm analyzing biopharmaceutical R&D performance, announces the launch of a Discovery study to assess research performance and identify trends that promise to shape the most successful Discovery organizations of the future. The study is part of the Pharmaceutical Benchmarking Forum’s initiatives for 2009 and already has a number of major company participants.

More: continued here

Filed under: Pharma Industry on November 11th, 2008